Prelude Therapeutics is based in Wilmington, Delaware. It has raised $125M in total funding. Latest round: Growth.
Prelude Therapeutics funding overview
Prelude Therapeutics is based in Wilmington, Delaware. Prelude Therapeutics has raised $125M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in July 2026. The round record for Prelude Therapeutics runs through 2026; nothing later has been disclosed.
Prelude Therapeutics at a glance
Total raised
$125M
Latest round
Growth
Latest round date
July 2026
Headquarters
Wilmington, Delaware
Frequently asked about Prelude Therapeutics funding
How much has Prelude Therapeutics raised?
Prelude Therapeutics has raised $125M in total disclosed funding across the rounds on record.
Who has invested in Prelude Therapeutics?
No investors are named on the public record for Prelude Therapeutics yet.
What was the latest Prelude Therapeutics funding round?
The most recent disclosed round is a Growth, announced in July 2026.
Where is Prelude Therapeutics based?
Prelude Therapeutics is based in Wilmington, Delaware.
When did Prelude Therapeutics last raise?
The last disclosed Prelude Therapeutics round closed in July 2026 at Growth.
Round data for Prelude Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Wilmington and backer lists below.
